We measured multiple parameters (i.e., clinical arthritis scores, joint tissue inflammation/destruction, serum levels of proinflammatory cytokines) in vivo experiments, and the results clearly showed that ATF6α is required for the CIA progression, as mice lacking ATF6α were protective against CIA. This evidence concerns the gene ATF6 and arthritic joint disease.